Cleared Traditional

K863607 - VIBRATRON II, VIBRATION SENSITIVITY TESTER (FDA 510(k) Clearance)

Class I Neurology device.

K863607 · Sensortek, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1986
Decision
78d
Days
Class 1
Risk

K863607 is an FDA 510(k) clearance for the VIBRATRON II, VIBRATION SENSITIVITY TESTER. Classified as Device, Vibration Threshold Measurement (product code LLN), Class I - General Controls.

Submitted by Sensortek, Inc. (Clifton, US). The FDA issued a Cleared decision on December 3, 1986 after a review of 78 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1200 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sensortek, Inc. devices

Submission Details

510(k) Number K863607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1986
Decision Date December 03, 1986
Days to Decision 78 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 148d · This submission: 78d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LLN Device, Vibration Threshold Measurement
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 882.1200
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.